Biologic therapy has shifted CRSwNP management towards a more personalized, mechanism-based approach. Upstream-targeted treatments represent an important step forward, particularly for patients with refractory or mixed disease. Future research should focus on biomarker-guided therapy and long-term clinical outcomes.
Building similarity graph...
Analyzing shared references across papers
Loading...
Zahedi et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69d896046c1944d70ce0735d — DOI: https://doi.org/10.1097/aci.0000000000001146
Farah Dayana Zahedi
Baharudin Abdullah
Pongsakorn Tantilipikorn
Current Opinion in Allergy and Clinical Immunology
Universiti Sains Malaysia
National University of Malaysia
Siriraj Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...